NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Angion Biomedica Corp. (NASDAQ: ANGN)’s merger with Elicio Therapeutics. Under the terms of the merger agreement, Elicio shareholders will receive newly issued shares of Angion common stock and current Angion shareholders are expected to own approximately 34.5% of the newly combined company. If you are an Angion shareholder, click here to learn more about your rights and options.
Cardiovascular Systems, Inc. (NASDAQ: CSII)’s sale to Abbott Laboratories for $20.00 per common share. If you are a Cardiovascular shareholder, click here to learn more about your rights and options.
NuVasive, Inc. (NASDAQ: NUVA)’s sale to Globus Medical, Inc. for 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. If you are a NuVasive shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
